US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Ovid Therapeutics Inc (OVID)
Ovid Therapeutics Inc (OVID) ニュース

OVID

Ovid Therapeutics (OVID)

Ovid Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OVID

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/03/11	22 : 08	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:OVID	Ovid Therapeutics Inc
2025/03/11	21 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2025/03/11	21 : 00	GlobeNewswire Inc.	Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results	NASDAQ:OVID	Ovid Therapeutics Inc
2025/03/06	06 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2025/03/03	22 : 00	GlobeNewswire Inc.	Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors	NASDAQ:OVID	Ovid Therapeutics Inc
2025/03/01	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2025/02/27	22 : 00	GlobeNewswire Inc.	Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference	NASDAQ:OVID	Ovid Therapeutics Inc
2025/02/25	09 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2025/02/15	07 : 41	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:OVID	Ovid Therapeutics Inc
2025/02/14	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2025/02/05	22 : 00	GlobeNewswire Inc.	Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference	NASDAQ:OVID	Ovid Therapeutics Inc
2025/01/29	23 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/12/17	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/12/17	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/12/02	22 : 00	GlobeNewswire Inc.	Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting	NASDAQ:OVID	Ovid Therapeutics Inc
2024/11/12	22 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OVID	Ovid Therapeutics Inc
2024/11/12	22 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/11/12	22 : 00	GlobeNewswire Inc.	Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results	NASDAQ:OVID	Ovid Therapeutics Inc
2024/10/31	21 : 00	GlobeNewswire Inc.	Ovid Therapeutics to Host Investor Event	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/26	21 : 00	GlobeNewswire Inc.	Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with Vigabatrin	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/12	06 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/12	06 : 36	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/12	05 : 57	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/11	21 : 00	GlobeNewswire Inc.	Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/04	21 : 00	GlobeNewswire Inc.	Ovid Therapeutics to Present at Upcoming September Investor Conferences	NASDAQ:OVID	Ovid Therapeutics Inc
2024/08/13	21 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OVID	Ovid Therapeutics Inc
2024/08/13	21 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/08/13	21 : 00	GlobeNewswire Inc.	Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results	NASDAQ:OVID	Ovid Therapeutics Inc
2024/08/08	21 : 00	GlobeNewswire Inc.	Ovid Therapeutics Appoints Dr. Amanda Banks, Experienced Biotech Leader & Physician as Chief Development Officer	NASDAQ:OVID	Ovid Therapeutics Inc
2024/08/03	06 : 22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:OVID

1 2 3 4 5 6 7 8 9 10 次へ >>

BNP Paribas Issuance

BetaShares Capital

Direxion Daily 20 plus Y...

SAGA SPDR ETFs Europe I ... (PK)

Greene County Bancorp

SGD vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約